Charles River Laboratories International CRL
NYSE CRL
$304.09 +5.07 (+1.70%)
As of: Oct 14, 2026 · 2:03 PM EDT

Charles River Laboratories International (CRL) Restructuring Costs (2017)

Updated

Charles River Laboratories International (CRL) reported Restructuring Costs of $18.1 million for Q4 2017.

Analysis

Charles River Laboratories International (CRL) Restructuring Costs (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.55 Bn 35.25 Bn 1.44 Bn
2 Medpace Holdings 17.35 Bn 15.42 Bn 201.64 Mn
3 Charles River Laboratories International 14.59 Bn 13.78 Bn 363.37 Mn
4 Icon 13.15 Bn 10.27 Bn 479.29 Mn
5 Fortrea Holdings 2.03 Bn 1.40 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 722.47 Mn -39.62 Mn 18.44 Mn
7 Evotec SE 504.11 Mn -1.11 Bn -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn
9 MindWalk Holdings 63.08 Mn 26.73 Mn 1.61 Mn
10 Natural Alternatives International 6.81 Mn -21.27 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 30, 2017 18.10 Mn
API Access

Charles River Laboratories International Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CRL&period=max&api_key=YOUR_API_KEY